Explore the latest in atrial fibrillation, including advances in treatment and stroke prevention, recent guidelines, and long-term outcomes.
This Clinical Challenge reviews ways to distinguish atrial ectopy, AV block, multifocal atrial tachycardia, and other supraventricular tachycardias from atrial fibrillation in patients with absent P waves, irregularly irregular R-R intervals, and f waves on electrocardiography.
This JAMA Insights Clinical Update reviews management approaches to atrial fibrillation (AF), including assessment of the need for anticoagulation, and controversies over the need for rhythm control and the role of catheter ablation for maintaining sinus rhythm and reducing AF-associated symptoms.
This systematic review and meta-analysis determines the association of BRAF and MEK inhibitor treatment with cardiovascular adverse events in patients with melanoma compared with BRAF inhibitor monotherapy.
This cohort study examines the risk of bleeding and stroke associated with surgical procedures and the value of perioperative management among patients with atrial fibrillation who use anticoagulants.
This population-based study evaluates the incidence of new-onset atrial fibrillation and assesses the incidence of in-hospital mortality associated with new-onset atrial fibrillation after transcatheter aortic valve implantation and surgical aortic valve replacement.
This network meta-analysis of randomized controlled trials examines the safety and efficacy of different antithrombotic regimens.
This study assesses whether a history of warfarin therapy in patients with atrial fibrillation is independently associated with subsequent bleeding or thrombotic events.
This cohort assesses the clinical effectiveness of direct oral anticoagulants vs warfarin for stroke prevention in patients with atrial fibrillation.
This narrative review examines the existing evidence of the differing response of embolic stroke of undetermined source to anticoagulation therapy and hypothesizes about pathophysiological factors that may underlie such variations.
This cohort study compares the risk of developing atrial fibrillation or major adverse cardiovascular events associated with ustekinumab vs a tumor necrosis factor (TNF) inhibitor therapy among patients with psoriasis or psoriatic arthritis.
This cohort study assesses treatment strategies and 1-year clinical outcomes of antithrombotic and CHF therapies for patients with newly diagnosed AF with concomitant congestive heart failure.
This systematic review and meta-analysis evaluates the association of preoperative renin-angiotensin system inhibitors with prevention of postoperative atrial fibrillation and adverse events among patients undergoing cardiac surgery.
This case report describes an adult woman with extensive skin lesions and epidermal spongiosis with neutrophilic and eosinophilic inflammation and telangiectasia from an allergic reaction to apixaban.
This randomized trial compares the effect of pulmonary vein isolation via catheter ablation vs rate and rhythm control using medical therapy on a composite outcome of death, disabling stroke, serious bleeding, or cardiac arrest in patients with atrial fibrillation (AF).
This open-label randomized trial compares the effect of pulmonary vein isolation via catheter ablation vs rate and rhythm control using drug therapy on the quality of life of patients with atrial fibrillation.
A man in his 70s with stage 4 chronic kidney disease and atrial fibrillation presented with 1 month of progressive dyspnea on exertion, orthopnea, and worsening lower extremity edema. What is your diagnosis?
This registry-based cohort study compares adverse event rates up to 3 years after initiation of treatment among patients receiving combination warfarin and aspirin therapy (without a therapeutic indication for aspirin use) vs those receiving warfarin monotherapy.
This registry-based cohort study assesses the differences in symptoms, treatment, and quality of life between Japanese men and women with atrial fibrillation.
This JAMA Patient Page describes why and how cardiac catheter ablation is used to correct atrial fibrillation and other heart rhythm abnormalities.
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: